192 related articles for article (PubMed ID: 18516669)
1. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.
Spatz SJ; Rue C; Schumacher D; Osterrieder N
Virus Genes; 2008 Aug; 37(1):69-80. PubMed ID: 18516669
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2.
Spatz SJ
Virus Res; 2010 May; 149(2):135-42. PubMed ID: 20109506
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.
Spatz SJ; Silva RF
Virus Genes; 2007 Aug; 35(1):41-53. PubMed ID: 16964553
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
[TBL] [Abstract][Full Text] [Related]
5. [Mutational analysis of Meq, RLORF4, RLORF12 and 132bpr genes of epidemic Marek's disease virus strains highly passaged on chicken embryo fibroblast].
Liu AL; Liu CJ; Zhang YP; Li JM; Shi WS; Yan FH; Zhang F; Cheng ZW
Bing Du Xue Bao; 2009 Sep; 25(5):368-75. PubMed ID: 19954114
[TBL] [Abstract][Full Text] [Related]
6. Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.
Spatz SJ; Volkening JD; Gimeno IM; Heidari M; Witter RL
Virus Genes; 2012 Dec; 45(3):526-36. PubMed ID: 22923089
[TBL] [Abstract][Full Text] [Related]
7. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
Spatz SJ; Rue CA
Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
[TBL] [Abstract][Full Text] [Related]
8. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
10. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
Witter RL; Kreager KS
Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.
Spatz SJ; Schat KA
Virus Genes; 2011 Jun; 42(3):331-8. PubMed ID: 21336949
[TBL] [Abstract][Full Text] [Related]
12. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses.
Witter RL
Avian Dis; 2002; 46(4):925-37. PubMed ID: 12495054
[TBL] [Abstract][Full Text] [Related]
13. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
14. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
[TBL] [Abstract][Full Text] [Related]
16. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.
Zhang YP; Bao KY; Sun GR; Lv HC; Cui HY; Gao YL; Wang XM; Liu CJ
Virus Genes; 2017 Jun; 53(3):386-391. PubMed ID: 28194622
[TBL] [Abstract][Full Text] [Related]
18. Vaccinal efficacy of molecularly cloned
Kim T; Spatz SJ; Dunn JR
J Gen Virol; 2020 May; 101(5):542-552. PubMed ID: 32134378
[TBL] [Abstract][Full Text] [Related]
19. Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.
Jarosinski KW; O'Connell PH; Schat KA
Virus Genes; 2003 May; 26(3):255-69. PubMed ID: 12876454
[TBL] [Abstract][Full Text] [Related]
20. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
Schat KA
Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
